期刊
MEDICINA-LITHUANIA
卷 57, 期 11, 页码 -出版社
MDPI
DOI: 10.3390/medicina57111141
关键词
CCL1-28; CXCL1-17; XCL1-2; CX3CL1; immune checkpoints; PD-1; PD-L1
资金
- Medical Faculty of the University Augsburg, Doctoral Funding Program
Chemokines play a key role in activating immune checkpoints in cervical cancer progression, affecting prognosis in various aspects. Understanding chemokines and immune checkpoint modulators is crucial for effective treatment of the disease.
Both clinical-pathological and experimental studies have shown that chemokines play a key role in activating the immune checkpoint modulator in cervical cancer progression and are associated with prognosis in tumor cell proliferation, invasion, angiogenesis, chemoresistance, and immunosuppression. Therefore, a clear understanding of chemokines and immune checkpoint modulators is essential for the treatment of this disease. This review discusses the origins and categories of chemokines and the mechanisms that are responsible for activating immune checkpoints in cervical dysplasia and cancer, chemokines as biomarkers, and therapy development that targets immune checkpoints in cervical cancer research.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据